Venous Thromboembolism Global Clinical Trials Review, H1, 2012
GlobalData
January 27, 2012 104 Pages - SKU: GBDT6797496
|
|
Venous Thromboembolism Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2012 provides data on the Venous Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
|
- Introduction
- Venous Thromboembolism
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Five Countries Contributing to Clinical Trials in Middle East and Africa
- Top Five Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Venous Thromboembolism
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Venous Thromboembolism Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Bayer AG
- Clinical Trial Overview of Bayer AG
- Sanofi
- Clinical Trial Overview of Sanofi
- Boehringer Ingelheim GmbH
- Clinical Trial Overview of Boehringer Ingelheim GmbH
- Astellas Pharma Inc.
- Clinical Trial Overview of Astellas Pharma Inc.
- GlaxoSmithKline plc
- Clinical Trial Overview of GlaxoSmithKline plc
- Pfizer Inc.
- Clinical Trial Overview of Pfizer Inc.
- AstraZeneca PLC
- Clinical Trial Overview of AstraZeneca PLC
- Bristol-Myers Squibb Company
- Clinical Trial Overview of Bristol-Myers Squibb Company
- Daiichi Sankyo Company, Limited
- Clinical Trial Overview of Daiichi Sankyo Company, Limited
- L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
- Clinical Trial Overview of L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
- ThromboGenics NV
- Clinical Trial Overview of ThromboGenics NV
- Daiichi Sankyo, Inc.
- Clinical Trial Overview of Daiichi Sankyo, Inc.
- Eisai Inc.
- Clinical Trial Overview of Eisai Inc.
- LEO Pharma A/S
- Clinical Trial Overview of LEO Pharma A/S
- Bayer Inc.
- Clinical Trial Overview of Bayer Inc.
- MEDRAD Interventional/POSSIS
- Clinical Trial Overview of MEDRAD Interventional/POSSIS
- ARYx Therapeutics, Inc.
- Clinical Trial Overview of ARYx Therapeutics, Inc.
- Medco Health Solutions Inc.
- Clinical Trial Overview of Medco Health Solutions Inc.
- Novartis AG
- Clinical Trial Overview of Novartis AG
- Takeda Pharmaceutical Company Limited
- Clinical Trial Overview of Takeda Pharmaceutical Company Limited
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- Utrecht University
- Clinical Trial Overview of Utrecht University
- Ottawa Hospital Research Institute
- Clinical Trial Overview of Ottawa Hospital Research Institute
- University of Calgary
- Clinical Trial Overview of University of Calgary
- Centre Hospitalier Universitaire de Saint Etienne
- Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne
- The University of Utah
- Clinical Trial Overview of The University of Utah
- Brigham and Women's Hospital
- Clinical Trial Overview of Brigham and Women's Hospital
- Università degli Studi dell'Insubria
- Clinical Trial Overview of Università degli Studi dell'Insubria
- Johann Wolfgang Goethe University Hospitals
- Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
- The University of Texas M. D. Anderson Cancer Center
- Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
- Hadassah Medical Organization
- Clinical Trial Overview of Hadassah Medical Organization
- Hopitaux Universitaires de Geneve
- Clinical Trial Overview of Hopitaux Universitaires de Geneve
- Ontario Clinical Oncology Group
- Clinical Trial Overview of Ontario Clinical Oncology Group
- Stanford University
- Clinical Trial Overview of Stanford University
- University of Padua
- Clinical Trial Overview of University of Padua
- St. Joseph's Healthcare Hamilton
- Clinical Trial Overview of St. Joseph's Healthcare Hamilton
- St. Orsola Hospital
- Clinical Trial Overview of St. Orsola Hospital
- University Hospital, Brest
- Clinical Trial Overview of University Hospital, Brest
- Slotervaart Hospital
- Clinical Trial Overview of Slotervaart Hospital
- HOPITAL LARIBOISIERE
- Clinical Trial Overview of HOPITAL LARIBOISIERE
- University of Missouri
- Clinical Trial Overview of University of Missouri
- Five Key Clinical Profiles
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
- List of Tables
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone, 2012*
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, BRIC Countries, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, G7 Countries, 2012*
- Venous Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, E7 Countries, 2012*
- Venous Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase, 2012*
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Venous Thromboembolism Therapeutics Market, Global, Suspended Clinical Trials, 2012*
- Venous Thromboembolism Therapeutics Market, Global, Terminated Clinical Trials, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by L.A.L Clinica Pesquisa e Desenvolvimento Ltda., 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by ThromboGenics NV, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by LEO Pharma A/S, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer Inc., 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by MEDRAD Interventional/POSSIS, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by ARYx Therapeutics, Inc., 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Medco Health Solutions Inc., 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Utrecht University, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Università degli Studi dell'Insubria, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ontario Clinical Oncology Group, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Padua, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph's Healthcare Hamilton, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Brest, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Slotervaart Hospital, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by HOPITAL LARIBOISIERE, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2012*
- List of Figures
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, BRIC Countries (%), 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, G7 Countries (%), 2012*
- Venous Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, E7 Countries (%), 2012*
- Venous Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
- Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
- Venous Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- GlobalData Methodology
Share this report
Other tasks Related Markets Drug Discovery Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
